|
|
ASRM BULLETIN Volume 3, Number 13 July 3,
2001
July Will Be Crucial in Stem Cell and Cloning
Debates
The Bush administration is facing an enormous amount of
pressure to make a decision on federal funding for embryonic stem cell
research. The issue, and the President’s indecision on it, has generated
reams of media coverage.
Thanks in part to the excellent work of
the Coalition for the Advancement of Medical Research (CAMR) of which ASRM
is a member, there has been a strong tide of pro-research momentum. Papers
all over the country have editorialized in favor of stem cell research,
and many conservative and anti-abortion Republicans have started to speak
out in favor of stem cell research.
Late last week Senator Orrin
Hatch (R- UT) released a letter to the President urging him to allow NIH
funding for embryonic stem cell work. On talk shows over the weekend
Hatch stated he felt the Senate was close to having enough votes to
overturn any Bush decision not to fund the research.
Meanwhile, GOP
leaders in the House, attempting to blunt the pro-stem cell research
momentum, released a statement yesterday urging Bush not to give in to the
“industry of death.”
Cloning
The high profile action
on stem cell research has driven cloning policy from the front pages.
However, the House is expected to continue its efforts to pass legislation
prohibiting human cloning when it comes back into session following
Independence Day.
There are two bills competing for attention in
the House. ASRM is supporting H.R. 2172, introduced by Representative Jim
Greenwood (R-PA). This bill would prohibit attempts to initiate a
pregnancy via human cloning, but allow research into therapeutic cloning
to continue.
The other bill, H.R. 1644, is a very broad bill that
prohibits any use of somatic cell nuclear transfer, even if done for
non-reproductive purposes.
The Independence Day recess would be an
excellent time for you to contact your Representative to express your
support for H.R. 2172 and your concern that H.R. 1644 is overly broad and
could have a chilling effect on important research. If you can make a call
this week, then simply look up your Representative’s number in your local
phone directory. Or you may call the Capitol Switchboard at 202-224-3121
and ask to be connected to your local member’s office. (If you need help
determining who your member is, contact our office or go to the “find your
member” section of the CAMR website at http://www.stemcellfunding.org/.)
Below
is the text of a document the ASRM public affairs staff has developed for
Congressional staff on the issue. Feel free to borrow from it to use in
your communications.
H.R. 2172, the Cloning Prohibition Act of
2001 Prohibits Cloning Babies, Protects Medical Research!
H.R. 2172, introduced by Representative Jim Greenwood
(R-8th/PA) and co-sponsored by Representatives Peter Deutsch (D-20th/FL)
and Diana DeGette (D-1st/Co), takes the necessary steps to prohibit human
reproductive cloning, while preserving the promising medical and
scientific possibilities offered by the technique of somatic cell nuclear
transfer SCNT). Doctors, legislators and the American people agree that at
this time we do not have the expertise to clone a normal, healthy human
child. The risks of reproductive cloning to the individual and to society
are too great and any present attempt to produce a human child through
cloning technology must be stopped.
H.R. 2172 makes it illegal to
use or attempt to use human SCNT with the intent to initiate a pregnancy,
and to transport the product of human SCNT with the knowledge that it will
be used to initiate a pregnancy.
H.R. 2172 protects the
possibilities of medical progress offered by SCNT by allowing doctors and
scientists to clone molecules, DNA, cells, or tissues; to clone or
otherwise create animals other than humans; and to pursue other
possibilities (biomedical, microbiological, or agricultural) not expressly
prohibited.
We must keep our freedom to allow important scientific
discoveries to be made.
-
Somatic Cell Nuclear Transfer
Technology holds promise for developing treatments for a myriad of
diseases: Alzheimer’s, Parkinson’s, diabetes, heart disease, stroke and
spinal cord injury, to name a few.
-
Therapeutic cloning from
somatic cells may help repair tissues and create new autologous tissues
(tissues that are produced from a patient’s own cells, genetically
identical to him or her), thereby eliminating the problems of transplant
rejection, the side effects of immune-suppressant drugs, and donor-organ
availability.
-
Through the study of newly
created cloned embryos, the process of genetic reprogramming could be
better understood, contributing to our understanding of the workings of
adult stem cells and the development of new therapies.
-
Cloning techniques could
provide an initial source of embryonic stem cells, which are pluripotent
(can be induced to develop into any type of specialized tissue) and are
thought to be immortal (capable of being cultured indefinitely). Our
scientific community is still in the beginning stages of this exciting
research on stem cells. Until more studies have been completed and more
discoveries made, we will not know whether adult stem cells will prove
to be as useful as embryonic cells. Until we know more, we must
pursue all areas of research open to us.
Competing Bill
We are concerned that a competing bill presently before
Congress, H.R. 1644, in its broad prohibition against human SCNT, might
chill research into new fertility therapies and embryo development, since
it is difficult to discern whether an embryo has been created via sexual
(in vitro fertilization) or asexual (cloning) methods. H.R. 1644 prohibits
not merely the creation of a cloned human child, but any use of human SCNT
technology for any other purpose, including scientific and medical
research.
H.R. 2172 recognizes that using SCNT in the development
of medical treatments is not the equivalent of reproductive
cloning.
Additionally, H.R. 2172 explicitly does not apply to
in vitro fertilization (which involves the combination of gametes, sperm
and egg, to form an embryo), the administration of fertility-enhancing
drugs, or the use of other medical procedures to assist a woman in
becoming or remaining pregnant. It also explicitly does not apply to the
use of mitochondrial, cytoplasmic or gene therapy.
Enforcement
Difficulty in enforcing the law and the fear that any use of
human SCNT would open the door to reproductive cloning have persuaded many
people to advocate a complete ban as provided for under H.R. 1644. But
whether or not all human SCNT is made illegal, it is still scientifically
and practically possible. However, the prospects under H.R. 2172 of
serious fines, jail time, and the accompanying losses of professional
licensure and the right to practice medicine are powerful disincentives to
doctors who might attempt to create a cloned pregnancy.
Registration
-
H.R. 2172 requires all
individuals who intend to perform human SCNT to register with the
Secretary of Health and Human Services and to sign a statement that they
are aware of the law's prohibitions and will not violate them.
-
H.R. 1644, since it bans all
use of human SCNT, provides no such requirement.
Civil Penalties
-
H.R. 2172: the penalty for
violating the law, including failure to register, shall not exceed the
greater of $1,000,000 or two times the amount of the gross pecuniary
gain derived from violation.
-
H.R. 1644: the penalty for
violating the law, if violation involved pecuniary gain, would be at
least $1,000,000 but not more than two times the amount of the gross
pecuniary gain derived from the violation, if that amount is greater
than $1,000,000. No penalty is specified for violations that do not
involve pecuniary gain.
Criminal
Penalties
Sign me up for the
ASRM Bulletin
Copyright 2000-2003 ASRM, All
Rights Reserved American Society for Reproductive
Medicine formerly The American Fertility Society Listed on Infertility
Resources Developed and hosted by Internet Health Resources
|